Advisory: Breast Implants: Risk of Lymphoma
Nov 24, 2017 Advisory: Breast Implants: Risk of Lymphoma Healthcare professionals including family physicians, obstetricians and gynaecologists, oncologists, general pathologists and hematopathologists, hematologists, radiologists, general and plastic surgeons. Rare cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) have been reported in Canada and internationally. Available data, from literature and international regulators, suggest that BIA-ALCL occurs more frequently following implantation of breast implants with textured surfaces compared to those with smooth surfaces. Healthcare professionals are encouraged to learn more about the signs, symptoms and testing steps to recognize and diagnose BIA-ALCL. Health Canada is working with manufacturers to update this safety information on the product labelling for breast implants.